CATALYSIS Advises Microdialysis Pioneer Dipylon Medical AB on the Sale of its Clinical Microdialysis Assets to M dialysis AB
CATALYSIS CAPITAL PARTNERS is pleased to announce that it acted as the exclusive financial advisor to Dipylon Medical AB on the sale of its clinical microdialysis assets and wholly-owned subsidiary in the United States to M Dialysis AB. Financial terms were not disclosed.
CATALYSIS Advises Microdialysis Pioneer CMA Microdialysis AB on the Sale of its Preclinical Microdialysis Assets to Harvard Bioscience, Inc.
CATALYSIS CAPITAL PARTNERS is pleased to announce that it acted as the exclusive strategic advisor to CMA Microdialysis AB on the sale of its preclinical microdialysis assets and related intellectual property to Harvard Bioscience, Inc. Financial terms were not disclosed.
CATALYSIS Advises Surgical Navigation and Robotics Developer The Acrobot Company Limited on the Sale to Stanmore Implants Worldwide Ltd.
CATALYSIS CAPITAL PARTNERS is pleased to announce that it acted as the exclusive strategic advisor to The Acrobot Company Limited in the sale to Stanmore Implants Worldwide Ltd. Financial terms were not disclosed.
Sam Williams, PhD Joins CATALYSIS as Senior Advisor
CATALYSIS CAPITAL PARTNERS is pleased to announce that Sam Williams, PhD has joined CATALYSIS as a Senior Advisor. Sam Williams has over 10 years’ experience in investment banking focusing on biotechnology and pharmaceuticals, most recently at Lehman Brothers where he held the position of Industry Group Leader for European Pharmaceuticals and Chemicals. Sam Williams was […]